Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

123
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
123
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The long-term outcome of the medial pivot knee arthroplasty system with minimum 25 years follow up.

The Knee·2026
Same author

Secretome and Pathway Analysis of Stress Induced Disc Degeneration In Vitro.

JOR spine·2026
Same author

Development of a Novel Holistic Assessment Strategy of TAVI-Induced Flow Restoration via Dimensionality Reduction Techniques.

Cardiovascular engineering and technology·2026
Same author

Validation of Aortic Blood Flow Simulations During Extracorporeal Circulation Using Phase Contrast Magnetic Resonance Imaging.

Artificial organs·2026
Same author

Interpretable Machine Learning for Feature-Based Classification of Platelet Activation in Rotary Blood Pumps.

Cardiovascular engineering and technology·2026
Same author

Noninvasive Predictive Model for Rapid Hemodynamic Optimization During Mechanical Circulatory Support.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026

Related Experiment Video

Updated: Dec 21, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.4K

COMBSecretomics: A pragmatic methodological framework for higher-order drug combination analysis using secretomics.

Efthymia Chantzi1,2, Michael Neidlin3, George A Macheras4

  • 1Cancer Pharmacology and Computational Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Plos One
|May 15, 2020
PubMed
Summary

A new framework, COMBSecretomics, enables analysis of multi-drug combinations beyond two drugs by examining cellular secretomic patterns. This advances drug discovery for complex diseases by exploring higher-order drug mixtures.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.1K

Related Experiment Videos

Last Updated: Dec 21, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.4K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.1K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Bioinformatics

Background:

  • Multi-drug treatments are crucial for complex diseases, but current discovery focuses on 2-drug anticancer therapies.
  • Existing methods lack the ability to analyze higher-order (more than two) drug combinations using secretomic data.
  • Secretomic patterns, representing protein release profiles, are vital for understanding cellular communication in disease.

Purpose of the Study:

  • Introduce COMBSecretomics, the first methodological framework for exhaustive second- and higher-order drug combination analysis of secretomic patterns.
  • Develop novel, model-free methods for analyzing complex drug mixtures.
  • Provide a standardized, reproducible approach applicable to various experimental platforms.

Main Methods:

  • Developed COMBSecretomics, a framework for analyzing multi-drug combinations.
  • Implemented two novel model-free combination analysis methods: a generalized highest single agent principle and hierarchical clustering.
  • Incorporated quality control for outlier elimination and non-parametric statistics for uncertainty quantification.

Main Results:

  • Demonstrated the framework's functionality through a proof-of-principle study on cartilage degradation.
  • Successfully identified second- and higher-order drug mixtures that modify secretomic patterns.
  • Established a standardized, reproducible format for secretomic drug combination analysis.

Conclusions:

  • COMBSecretomics is the first framework enabling secretome-related second- and higher-order drug combination analysis.
  • The framework can be applied to drug discovery, clinical practice, and understanding disease-related cell communication.
  • This methodology expands the scope of drug combination studies beyond current limitations.